EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

JCO Precision Oncology

ISSN 2473-4284 · American Society of Clinical Oncology (ASCO)

Neueste Artikel

  1. Cancer Risks Associated With Germline BARD1 Pathogenic/Likely Pathogenic Variants: A Multicenter Study of 445 Families

    Jeanne P. Homer, Michael J. Demeure, Yuhui Yao, Kristen Hanson, Brenda Ramczyk, Emily C. Lichtenberg, Stephanie A. Cohen, Kate Crow, Michelle E. Florido, Karen P. Powell, Cari M. Koerner, Mary E. DeGrandchamp, Corinne Zrada, Maylie B. Gonzales, Rachel A. Collier, Emily S. Chien, Chelsey B. Torres, Jonathan Lin, Sara Sigsbee, Shealyn G. Smith, Tammy A. Adar, Darcy K. Berry, Kathleen Gewandter, Nicole Wright, Leigha Senter, Jordan Brown, Maria J. Baker, Kelly Morse, Rachel Scouten, Sandra M. Brown, Dillon van den Berg, Lillian B. Tran, Kimberly Childers, Ora Gordon, Elysa Bond, Brianna Pagan, Stephanie Woo, Heather Mandich, Deepika Nathan, Beth Y. Karlan

    Erschienen: 2026-11DOI: 10.1200/po-26-00417

  2. Longitudinal Pancreatic Imaging Findings in BRCA1 , BRCA2 , ATM, and PALB2 Heterozygotes Undergoing Pancreatic Cancer Surveillance: A Prospective PRECEDE Consortium Study

    Samantha Kasselman, Jessica M. Long, Tiffiney R. Hartman, Kieran Hawthorne, John J. Graff, Fay Kastrinos, Aimee L. Lucas, Bryson W. Katona, Todd W. Bauer, Yan Bi, Erkut Borazanci, Randall E. Brand, Teri Brentnall, Darren Carpizo, Daniel C. Chung, Sarah E. Coughlin, Timothy R. Donahue, Beth Dudley, Julie Earl, Jessica N. Everett, James Farrell, Eitan Friedman, Talia Golan, Ora K. Gordon, Robert C. Grant, William Greenhalf, Aaron Grossberg, Zoltán Hajnády, Sigurdís Haraldsdóttir, Philip A. Hart, Peter Hegyi, Melissa E. Hogg, Spring Holter, Gregory E. Idos, Diana Ishak, Vivek Kaul, Kelsey Klute, Sonia S. Kupfer, Kimberly Ku, Richard Kwon

    Erschienen: 2026-11DOI: 10.1200/po-26-00955

  3. Development and Validation of a Computational Histology Artificial Intelligence–Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials

    Christopher J. Sweeney, Vrishab Krishna, Viswesh Krishna, Akshay Neema, Asit Tarsode, Vinod V. Subhash, Lisa G. Horvath, James G. Kench, Martin R. Stockler, Sonia Yip, Hayley Thomas, Umang Swami, Haochen Zhang, Snehal Sonawane, Waleed M. Abuzeid, Vivek Nimgaonkar, Ekin Tiu, Drew Watson, Lesli Kiedrowski, Trevor J. Royce, David D. Yang, Phuoc T. Tran, Charles J. Ryan, Paul L. Nguyen, Alicia K. Morgans, Anirudh Joshi, Neeraj Agarwal, Ian D. Davis

    Erschienen: 2026-07DOI: 10.1200/po-26-00321

  4. Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO

    Brian W. Labadie, Aleksandar Obradovic, Alexander G. Raufi, Urszula N. Wasko, Lorenzo Tomassoni, Liner Ge, Michael May, Manan Vij, Li Li, Isabelle Ross, Sarah S. Sedycius, Naomi Sender, Nickolas Dreher, Linda Wu, Sinan Abuzaid, Alina Iuga, Parin Shah, Julia D. Wulfkuhle, Susan Bates, Winston Wong, Ilenia Pellicciotta, Alex K. Lyashchenko, Howard Safran, Benjamin Izar, Emanuel F. Petricoin, Serge Cremers, Aik Choon Tan, Shing Lee, Andrea Califano, Kenneth P. Olive, Gulam A. Manji

    Erschienen: 2026-06DOI: 10.1200/po-26-00138

  5. Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan–Treated Human Epidermal Growth Factor Receptor 2–Positive Gastric Cancer

    Ansh Kapil, Henrik Failmezger, Yu Fu, Andreas Spitzmüller, Jessica Chan, Susanne Haneder, Anatoliy Shumilov, Alice Barkell, Toshihiro Oguma, Koichiro Inaki, Fumitaka Suto, John Allard, Jeeyun Lee, Arthur W. Lambert, Markus Schick, J. Carl Barrett, Günter Schmidt, Hadassah Sade, Mark Gustavson, Danielle Carroll, Fabiola Cecchi

    Erschienen: 2026-05DOI: 10.1200/po-25-00823

  6. Biomarker Testing Rates and Patterns in Patients With Metastatic Non–Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices

    Makenzi Evangelist, Bo Wang, James E. Butrynski, John Paschold, Patrick J. Ward, David M. Waterhouse, Robert M. Jotte, Kashif Ali, Donald A. Richards, Kartik Konduri, Anton Melnyk, Rami S. Owera, David Hakimian, Habib Ghaddar, Eric M. Lander, Nicholas J. Robert, Jennifer L. Yori, Vikalp Upadhyay, David R. Spigel, Melissa L. Johnson

    Erschienen: 2026-04DOI: 10.1200/po-25-00832

  7. Evaluating Tumor Burden as a Predictive Biomarker for Epidermal Growth Factor Receptor Targeted Kinase Inhibitor Therapy in Advanced Non–Small Cell Lung Cancer

    Rika Terashima, Judy Fan, Fatma Gunturkun, Grant Nieda, Xiaomei Fan, Emily M. Rodriguez, Annabel X. Tan, Stefan Thottunkal, Maggie Shaw, Chloe C. Su, Aparajita Khan, Victoria Y. Ding, Ingrid Luo, Mina Satoyoshi, Archana Bhat, Bo Gu, Solomon M. Henry, Timothy J. Ellis-Caleo, Michelle Odden, Allison W. Kurian, Joel W. Neal, Heather A. Wakelee, Julie T. Wu, Summer S. Han

    Erschienen: 2026-04DOI: 10.1200/po-25-00884

  8. Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation

    Jonathan Baden, Cheng-Ho Jimmy Lin, Andrew T. Anfora, Jonathan Beer, Karl Bisselou, Jennifer Bungo, Adam S. Corner, Tyler Danek, Jennifer Dickey, James H. Godsey, Donald J. Johann, Gregory Jones, George Karlin-Neumann, Jessica L. Larson, Jerry S.H. Lee, Li Liu, Dorys Lopez Ramos, David Merriam, Melanie Palomares, Carol E. Pena, Jessica Rathbun, Kate Rhodes, Jaime E. Connolly Rohrbach, Banu Saritas-Yildirim, Mark Sausen, Shile Zhang, Lauren C. Leiman

    Erschienen: 2026-01DOI: 10.1200/po-25-00267

  9. HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing–Based Assays With Immunohistochemistry

    Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto, Yoshiaki Nakamura, Shigenori Kadowaki, Makoto Ueno, Shogen Boku, Yoshito Komatsu, Eiji Oki, Akitaka Makiyama, Norio Nonomura, Chigusa Morizane, Hidemichi Watari, Susumu Okano, Hiroji Iwata, Kenjiro Namikawa, Yutaka Hatanaka, Kanako C. Hatanaka, Kenichi Taguchi, David Spetzler, Milan Radovich, Daniel Magee, Takayuki Yoshino, Matthew Oberley, Takeshi Kuwata

    Erschienen: 2026-01DOI: 10.1200/po-25-00413

Jahrgänge

2026 · 1472025 · 3132024 · 2862023 · 2352022 · 2242021 · 2052020 · 1602019 · 1862018 · 1642017 · 96

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.